Neovian Partners concluded the strategic due diligence of Optoprim Group on behalf of NCI
Paris, 13 December 2022: The strategy consulting firm Neovian Partner has carried out a strategic due diligence of the group Optoprim, a company specialising in photonic technologies.
Founded in 1994, Optoprim is a specialist in photonics who offer and advise clients regarding photonic technologies from the component to complete turnkey technical solutions to professionals working in research or in industry.
Neovian Partners worked with NCI to evaluate the market potential in France, Germany and Italy, countries where Optoprim is present, understand their positioning in the photonics ecosystem and the elements which differentiate them from their competitors.
Neovian Partners has worked for other companies specialised in photonics and optical components several times in the past.
“The group has a strong international dimension and differentiate themselves in their capacity to accompany clients throughout the entirety of a project thanks to their strong R&D capacities and their proven ability to deliver bespoke turnkey solutions.”
Kevin Bailey, Partner
About Neovian Partners
is a consulting firm specializing in the creation of tailored solutions in Strategy, Business Due Diligence, Strategic Screening and HR/Leadership, serving fast-growing investment funds, SMEs and MSCs. Based in Paris and Lyon with a team of about 30 consultants, Neovian Partners is also present internationally, with a network of partner firms with more than 500 employees in 21 countries. Neovian Partners is a generalist firm but with a particularly important project history in software, IT, Internet, Industry, Health and MedTechs, as well as in many niche sectors. More information on : www.neovianpartners.com